Table 4.
Share of disease burden averted by each intervention using US$500 per DALY averted CET and US$200 per DALY averted CET
| k = $500 per DALY averted | k = $200 per DALY averted | |||||||
|---|---|---|---|---|---|---|---|---|
| Interventions | Population NHB (DALYs averted) | % of overall Disease burden averted* | % range of disease-specific burden averted¥ | Population NHB (DALYs averted) | % of overall disease burden averted* | % range of disease-specific burden averted¥ | ||
| Do-nothing comparator | ||||||||
| Intervention [1] | 160,000 | 1.52% | 160,000 to 400,000 (4–10%) | − 200,000 | − 1.90% | − 200,000 to 400,000 (− 5% to 10%) | ||
| Intervention [2] | − 56,000 | − 0.53% | − 56,000 to 56,000 (− 2.8% to 2.8%) | − 224,000 | − 2.13% | − 224,000 to 56,000 (− 11.2% to 2.8%) | ||
| Intervention [3] | 157,500 | 1.5% | 157,500 to 187,500 (10.5–12.5%) | 112,500 | 1.07% | 75,000 to 187,500 (7.5–12.5%) | ||
| Intervention [4] | 30,000 | 0.29% | 30,000 to 37,500 (1–1.25%) | 18,750 | 0.18% | 18,750 to 37,500 (0.63–1.25%) | ||
In this case, we are assuming that the health opportunity costs (marginal productivity estimates) for disease-specific budgets are equivalent to those of the entire health system (i.e., we assume efficient budget setting)
DALYs disability-adjusted life years, NHB net health benefit
% disease burden = population NHB/total DALY burden
*a +ve change signifies decline in burden; a −ve change signifies an increase in burden
¥Disease-specific burden for Intervention 1: 4 million DALYs; Intervention 2: 2 million DALYs; Intervention 3: 1.5 million DALYs; Intervention 4: 3 million DALYs